本月全球药品研发进展取得成效的药物有53个,较上月减少了15个,除进入Ⅲ期临床阶段的药物数量比上月有所增加外,进入注册和注册前阶段的药品数量均减少。进入注册阶段的有21个,比上月大幅减少18个。其中8个为全球首次注册的新活性物质、新制剂和新适应证,其余13个均为在新市场补充注册。本月全球首次注册8个药品,较上月增加2个。其中 Fifty-three drugs were delivered in the global pharmaceutical research and development month this month, a 15-month drop from the previous month. The number of drugs entering the pre-registration and pre-registration phase was lower than the previous month, except for the increase in the number of drugs entering Phase III clinical trials . There were 21 registrations, a sharp decrease of 18 from the previous month. Eight of these were the first new active substances, new preparations and new indications registered in the world, and the remaining 13 were newly registered in the new markets. This month the world’s first registration of eight drugs, an increase of 2 last month. among them